Covista Inc. (CVSA)
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-09-04
$128.09+0.35%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CVSA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is still in the top half of its industry but slipped notably this past month — worth watching.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -40.6% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 7.3% |
Growth built into the price is above our model estimate.
The price assumes 48.0 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 9 industry peers
CVSA — director transition
Dated 2026-07-28
Director — Ms. Emily Chiu, Ms. Leslie Storms: Appointment of two new independent directors to the Board.
Why it matters: Doing well would help Covista in healthcare education.
Watch forManagement says they are making good progress on the Purpose at Scale strategy.
Also watch forManagement says there are delays or setbacks in the Purpose at Scale strategy.
Why it matters: If they exceed guidance, it shows strong demand and good growth strategies.
Supportive ifQ3 revenue guidance exceeds $1,945 million, indicating strong growth.
Worry ifQ3 revenue guidance remains at or below $1,930 million.
Why it matters: The new board members bring expertise that could enhance strategic decision-making. Their impact can shape Covista’s growth trajectory.
Watch forNew plans or partnerships were shared after the board appointments.
Also watch forNo new plans or partnerships were shared in six months after the appointments.
Why it matters: Higher revenue guidance shows confidence in sales growth and market demand.
Supportive ifManagement raises revenue guidance for FY 2026. It is now beyond current estimates.
Worry ifManagement keeps or lowers revenue guidance for FY 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$146 on $10,000 · ±1.5% | How much price usually moves either way. |
| Bad day | $420 loss on $10,000 · 4.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,214 loss on $10,000 · 42.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If adjusted EPS is below $7.95, it shows profit challenges. This may worry investors.
Worry ifAdjusted EPS in Q3 fiscal 2026 reported below $7.95.
Less concerning ifAdjusted EPS in Q3 fiscal 2026 meets or exceeds $7.95.
Why it matters: New partnerships can help Covista connect graduates with jobs. This boosts enrollment and revenue.
Supportive ifAnnouncement of new partnerships with at least two healthcare systems.
Worry ifNo new partnerships announced within the next six months.
Why it matters: An increase would signal strong earnings growth and effective cost management.
Supportive ifAdjusted EPS guidance is now above $8.15. This shows strong performance.
Worry ifAdjusted EPS guidance stays at or below $8.05.
Why it matters: If revenue growth is below 8%, it shows weaker performance. This could hurt investor confidence.
Worry ifQ3 fiscal 2026 revenue growth reported below 8%.
Less concerning ifQ3 fiscal 2026 revenue growth meets or exceeds 8%.
Why it matters: The revenue guidance for fiscal year 2027 indicates expected growth. Confirmation shows the company is on track.
Supportive ifFiscal year 2027 revenue confirmed in the range of $2,050 million to $2,090 million.
Worry ifRevenue guidance is now below $2,050 million.
Why it matters: Share repurchases can signal management's confidence in the company's value. It can also support earnings per share growth.
Supportive ifThere is an announcement for more share repurchases over $100 million.
Worry ifNo new share repurchase announcements in the next quarter.